EDC Software is growing rapidly in the drug testing and drug approval world. The requirements from the government are strict and several phases of drug trials must be completed before the FDA will permit a new drug to be sold. OMCM has developed award winning EDC software that is in great demand. The company is growing at more than 100% per year and has many large orders on its books. This company is currently valued at under $40 million and looking forward is very good value at its current price of 0.60 per share.
$0.59 (07/19/08)
